Leukocyte-derived biomimetic nanoparticulate drug delivery systems for cancer therapy

This review summarizes the biological features and recent preclinical investigations of leukocyte-derived nanoparticulate delivery vehicles with special focus on the cell-mediated approaches that have been developed to overcome the physiological barriers for drug delivery.301